Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 102 entries
Sorted by: Best Match Show Resources per page
Boron-Enhanced Growth of Micron-Scale Carbon-Based Nanowalls: A Route toward High Rates of Electrochemical Biosensing.

ACS applied materials & interfaces

Siuzdak K, Ficek M, Sobaszek M, Ryl J, Gnyba M, Niedziałkowski P, Malinowska N, Karczewski J, Bogdanowicz R.
PMID: 28345350
ACS Appl Mater Interfaces. 2017 Apr 19;9(15):12982-12992. doi: 10.1021/acsami.6b16860. Epub 2017 Apr 06.

In this study, we have demonstrated the fabrication of novel materials called boron-doped carbon nanowalls (B:CNWs), which are characterized by remarkable electrochemical properties such as high standard rate constant (k°), low peak-to-peak separation value (ΔE) for the oxidation and...

Cite
Siuzdak K, Ficek M, Sobaszek M, et al. Boron-Enhanced Growth of Micron-Scale Carbon-Based Nanowalls: A Route toward High Rates of Electrochemical Biosensing. ACS Appl Mater Interfaces. 2017;9(15):12982-12992doi: 10.1021/acsami.6b16860.
Siuzdak, K., Ficek, M., Sobaszek, M., Ryl, J., Gnyba, M., Niedziałkowski, P., Malinowska, N., Karczewski, J., & Bogdanowicz, R. (2017). Boron-Enhanced Growth of Micron-Scale Carbon-Based Nanowalls: A Route toward High Rates of Electrochemical Biosensing. ACS applied materials & interfaces, 9(15), 12982-12992. https://doi.org/10.1021/acsami.6b16860
Siuzdak, Katarzyna, et al. "Boron-Enhanced Growth of Micron-Scale Carbon-Based Nanowalls: A Route toward High Rates of Electrochemical Biosensing." ACS applied materials & interfaces vol. 9,15 (2017): 12982-12992. doi: https://doi.org/10.1021/acsami.6b16860
Siuzdak K, Ficek M, Sobaszek M, Ryl J, Gnyba M, Niedziałkowski P, Malinowska N, Karczewski J, Bogdanowicz R. Boron-Enhanced Growth of Micron-Scale Carbon-Based Nanowalls: A Route toward High Rates of Electrochemical Biosensing. ACS Appl Mater Interfaces. 2017 Apr 19;9(15):12982-12992. doi: 10.1021/acsami.6b16860. Epub 2017 Apr 06. PMID: 28345350.
Copy Download .nbib Format: NLM
The structure and energetics of arsenic(III) oxide intercalated by ionic azides.

Dalton transactions (Cambridge, England : 2003)

Guńka PA, Kraszewski K, Chen YS, Zachara J.
PMID: 25017432
Dalton Trans. 2014 Sep 07;43(33):12776-83. doi: 10.1039/c4dt01569j.

Unprecedented intercalates of arsenic(iii) oxide with potassium azide and ammonium azide have been obtained and characterized by single crystal X-ray diffraction. The compounds are built of As2O3 sheets separated by charged layers of cations and azide anions perpendicular to...

Cite
Guńka PA, Kraszewski K, Chen YS, et al. The structure and energetics of arsenic(III) oxide intercalated by ionic azides. Dalton Trans. 2014;43(33):12776-83doi: 10.1039/c4dt01569j.
Guńka, P. A., Kraszewski, K., Chen, Y. S., & Zachara, J. (2014). The structure and energetics of arsenic(III) oxide intercalated by ionic azides. Dalton transactions (Cambridge, England : 2003), 43(33), 12776-83. https://doi.org/10.1039/c4dt01569j
Guńka, Piotr A, et al. "The structure and energetics of arsenic(III) oxide intercalated by ionic azides." Dalton transactions (Cambridge, England : 2003) vol. 43,33 (2014): 12776-83. doi: https://doi.org/10.1039/c4dt01569j
Guńka PA, Kraszewski K, Chen YS, Zachara J. The structure and energetics of arsenic(III) oxide intercalated by ionic azides. Dalton Trans. 2014 Sep 07;43(33):12776-83. doi: 10.1039/c4dt01569j. PMID: 25017432.
Copy Download .nbib Format: NLM
Occurrence of sleep-related breathing disorders in patients with chronic urticaria at its asymptomatic or oligosymptomatic stages.

Postepy dermatologii i alergologii

Perkowska J, Kruszewski J, Gutkowski P, Chciałowski A, Kłos K.
PMID: 26985182
Postepy Dermatol Alergol. 2016 Feb;33(1):63-7. doi: 10.5114/pdia.2015.48052. Epub 2016 Feb 29.

INTRODUCTION: Chronic urticaria (CU), in view of its manifestations (pruritus, wheals), chronic and recurrent nature is very bothersome for patients and significantly influences their quality of life.AIM: To assess the importance of sleep problems and sleep-related breathing disorders (SRBDs)...

Cite
Perkowska J, Kruszewski J, Gutkowski P, et al. Occurrence of sleep-related breathing disorders in patients with chronic urticaria at its asymptomatic or oligosymptomatic stages. Postepy Dermatol Alergol. 2016;33(1):63-7doi: 10.5114/pdia.2015.48052.
Perkowska, J., Kruszewski, J., Gutkowski, P., Chciałowski, A., & Kłos, K. (2016). Occurrence of sleep-related breathing disorders in patients with chronic urticaria at its asymptomatic or oligosymptomatic stages. Postepy dermatologii i alergologii, 33(1), 63-7. https://doi.org/10.5114/pdia.2015.48052
Perkowska, Jolanta, et al. "Occurrence of sleep-related breathing disorders in patients with chronic urticaria at its asymptomatic or oligosymptomatic stages." Postepy dermatologii i alergologii vol. 33,1 (2016): 63-7. doi: https://doi.org/10.5114/pdia.2015.48052
Perkowska J, Kruszewski J, Gutkowski P, Chciałowski A, Kłos K. Occurrence of sleep-related breathing disorders in patients with chronic urticaria at its asymptomatic or oligosymptomatic stages. Postepy Dermatol Alergol. 2016 Feb;33(1):63-7. doi: 10.5114/pdia.2015.48052. Epub 2016 Feb 29. PMID: 26985182; PMCID: PMC4793057.
Copy Download .nbib Format: NLM
Genotoxicity and Mutagenicity of Inosine Pranobex.

Journal of veterinary research

Tobólska S, Terpiłowska S, Jaroszewski J, Siwicki AK.
PMID: 30364916
J Vet Res. 2018 Oct 24;62(2):207-213. doi: 10.2478/jvetres-2018-0030. eCollection 2018 Jun.

INTRODUCTION: Inosine pranobex (Methisoprinol, ISO, Isoprinosine) is an immuno-modulatory antiviral drug that has been licensed since 1971 in several countries worldwide. In humans, the drug is approved for the treatment of viral infections, and it might also have therapeutic...

Cite
Tobólska S, Terpiłowska S, Jaroszewski J, et al. Genotoxicity and Mutagenicity of Inosine Pranobex. J Vet Res. 2018;62(2):207-213doi: 10.2478/jvetres-2018-0030.
Tobólska, S., Terpiłowska, S., Jaroszewski, J., & Siwicki, A. K. (2018). Genotoxicity and Mutagenicity of Inosine Pranobex. Journal of veterinary research, 62(2), 207-213. https://doi.org/10.2478/jvetres-2018-0030
Tobólska, Sylwia, et al. "Genotoxicity and Mutagenicity of Inosine Pranobex." Journal of veterinary research vol. 62,2 (2018): 207-213. doi: https://doi.org/10.2478/jvetres-2018-0030
Tobólska S, Terpiłowska S, Jaroszewski J, Siwicki AK. Genotoxicity and Mutagenicity of Inosine Pranobex. J Vet Res. 2018 Oct 24;62(2):207-213. doi: 10.2478/jvetres-2018-0030. eCollection 2018 Jun. PMID: 30364916; PMCID: PMC6200294.
Copy Download .nbib Format: NLM
Corrigendum to "Ordered titanium templates functionalized by gold films for biosensing applications - Towards non-enzymatic glucose detection" [Talanta 166 (2017) 207-214].

Talanta

Grochowska K, Szkoda M, Karczewski J, Śliwiński G, Siuzdak K.
PMID: 28340757
Talanta. 2017 May 15;167:537. doi: 10.1016/j.talanta.2017.02.052. Epub 2017 Mar 06.

No abstract available.

Cite
Grochowska K, Szkoda M, Karczewski J, et al. Corrigendum to "Ordered titanium templates functionalized by gold films for biosensing applications - Towards non-enzymatic glucose detection" [Talanta 166 (2017) 207-214]. Talanta. 2017;167:537doi: 10.1016/j.talanta.2017.02.052.
Grochowska, K., Szkoda, M., Karczewski, J., Śliwiński, G., & Siuzdak, K. (2017). Corrigendum to "Ordered titanium templates functionalized by gold films for biosensing applications - Towards non-enzymatic glucose detection" [Talanta 166 (2017) 207-214]. Talanta, 167537. https://doi.org/10.1016/j.talanta.2017.02.052
Grochowska, Katarzyna, et al. "Corrigendum to "Ordered titanium templates functionalized by gold films for biosensing applications - Towards non-enzymatic glucose detection" [Talanta 166 (2017) 207-214]." Talanta vol. 167 (2017): 537. doi: https://doi.org/10.1016/j.talanta.2017.02.052
Grochowska K, Szkoda M, Karczewski J, Śliwiński G, Siuzdak K. Corrigendum to "Ordered titanium templates functionalized by gold films for biosensing applications - Towards non-enzymatic glucose detection" [Talanta 166 (2017) 207-214]. Talanta. 2017 May 15;167:537. doi: 10.1016/j.talanta.2017.02.052. Epub 2017 Mar 06. PMID: 28340757.
Copy Download .nbib Format: NLM
Comparison of two models of hospital rehabilitation in patients after coronary artery bypass grafting.

Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery

Karaszewski D.
PMID: 26336403
Kardiochir Torakochirurgia Pol. 2014 Mar;11(1):86-9. doi: 10.5114/kitp.2014.41940. Epub 2014 Mar 27.

INTRODUCTION: Taking into consideration the rise in ischemic heart disease and the increasing number of performed cardiac surgery procedures, attempts have been made to prepare an optimal rehabilitation program enabling the effective improvement of patient condition in the shortest...

Cite
Karaszewski D. Comparison of two models of hospital rehabilitation in patients after coronary artery bypass grafting. Kardiochir Torakochirurgia Pol. 2014;11(1):86-9doi: 10.5114/kitp.2014.41940.
Karaszewski, D. (2014). Comparison of two models of hospital rehabilitation in patients after coronary artery bypass grafting. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery, 11(1), 86-9. https://doi.org/10.5114/kitp.2014.41940
Karaszewski, Daniel. "Comparison of two models of hospital rehabilitation in patients after coronary artery bypass grafting." Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery vol. 11,1 (2014): 86-9. doi: https://doi.org/10.5114/kitp.2014.41940
Karaszewski D. Comparison of two models of hospital rehabilitation in patients after coronary artery bypass grafting. Kardiochir Torakochirurgia Pol. 2014 Mar;11(1):86-9. doi: 10.5114/kitp.2014.41940. Epub 2014 Mar 27. PMID: 26336403; PMCID: PMC4283915.
Copy Download .nbib Format: NLM
Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology.

Postepy dermatologii i alergologii

Nowicki R, Trzeciak M, Wilkowska A, Sokołowska-Wojdyło M, Ługowska-Umer H, Barańska-Rybak W, Kaczmarski M, Kowalewski C, Kruszewski J, Maj J, Silny W, Śpiewak R, Petranyuk A.
PMID: 26366146
Postepy Dermatol Alergol. 2015 Aug;32(4):239-49. doi: 10.5114/pdia.2015.53319. Epub 2015 Aug 12.

Atopic dermatitis (AD) is a condition frequently encountered in medical practices across the country. More than 60% of children with AD are at risk to develop allergic rhinitis or asthma (the atopic march). Patients with AD have a unique...

Cite
Nowicki R, Trzeciak M, Wilkowska A, et al. Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology. Postepy Dermatol Alergol. 2015;32(4):239-49doi: 10.5114/pdia.2015.53319.
Nowicki, R., Trzeciak, M., Wilkowska, A., Sokołowska-Wojdyło, M., Ługowska-Umer, H., Barańska-Rybak, W., Kaczmarski, M., Kowalewski, C., Kruszewski, J., Maj, J., Silny, W., Śpiewak, R., & Petranyuk, A. (2015). Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology. Postepy dermatologii i alergologii, 32(4), 239-49. https://doi.org/10.5114/pdia.2015.53319
Nowicki, Roman, et al. "Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology." Postepy dermatologii i alergologii vol. 32,4 (2015): 239-49. doi: https://doi.org/10.5114/pdia.2015.53319
Nowicki R, Trzeciak M, Wilkowska A, Sokołowska-Wojdyło M, Ługowska-Umer H, Barańska-Rybak W, Kaczmarski M, Kowalewski C, Kruszewski J, Maj J, Silny W, Śpiewak R, Petranyuk A. Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology. Postepy Dermatol Alergol. 2015 Aug;32(4):239-49. doi: 10.5114/pdia.2015.53319. Epub 2015 Aug 12. PMID: 26366146; PMCID: PMC4565838.
Copy Download .nbib Format: NLM
Evaluation of the placebo effect in the trials of allergen immunotherapy effectiveness: meta-analysis of randomized and placebo-controlled trials.

Postepy dermatologii i alergologii

Abramowicz M, Kruszewski J, Chciałowski A.
PMID: 30618532
Postepy Dermatol Alergol. 2018 Dec;35(6):620-625. doi: 10.5114/ada.2018.77614. Epub 2018 Nov 13.

INTRODUCTION: The total effect of the method of treatment is composed of its specific activity depending on its impact on the disease mechanism and the non-specific activity, i.e. the placebo effect. Many methods of treatment make use of such...

Cite
Abramowicz M, Kruszewski J, Chciałowski A. Evaluation of the placebo effect in the trials of allergen immunotherapy effectiveness: meta-analysis of randomized and placebo-controlled trials. Postepy Dermatol Alergol. 2018;35(6):620-625doi: 10.5114/ada.2018.77614.
Abramowicz, M., Kruszewski, J., & Chciałowski, A. (2018). Evaluation of the placebo effect in the trials of allergen immunotherapy effectiveness: meta-analysis of randomized and placebo-controlled trials. Postepy dermatologii i alergologii, 35(6), 620-625. https://doi.org/10.5114/ada.2018.77614
Abramowicz, Michał, et al. "Evaluation of the placebo effect in the trials of allergen immunotherapy effectiveness: meta-analysis of randomized and placebo-controlled trials." Postepy dermatologii i alergologii vol. 35,6 (2018): 620-625. doi: https://doi.org/10.5114/ada.2018.77614
Abramowicz M, Kruszewski J, Chciałowski A. Evaluation of the placebo effect in the trials of allergen immunotherapy effectiveness: meta-analysis of randomized and placebo-controlled trials. Postepy Dermatol Alergol. 2018 Dec;35(6):620-625. doi: 10.5114/ada.2018.77614. Epub 2018 Nov 13. PMID: 30618532; PMCID: PMC6320494.
Copy Download .nbib Format: NLM
Mechanism of Iodine(III)-Promoted Oxidative Dearomatizing Hydroxylation of Phenols: Evidence for a Radical-Chain Pathway.

Chemistry (Weinheim an der Bergstrasse, Germany)

Kraszewski K, Tomczyk I, Drabinska A, Bienkowski K, Solarska R, Kalek M.
PMID: 32608529
Chemistry. 2020 Sep 04;26(50):11584-11592. doi: 10.1002/chem.202002026. Epub 2020 Aug 10.

The oxidative dearomatization of phenols with the addition of nucleophiles to the aromatic ring induced by hypervalent iodine(III) reagents and catalysts has emerged as a highly useful synthetic approach. However, experimental mechanistic studies of this important process have been...

Cite
Kraszewski K, Tomczyk I, Drabinska A, et al. Mechanism of Iodine(III)-Promoted Oxidative Dearomatizing Hydroxylation of Phenols: Evidence for a Radical-Chain Pathway. Chemistry. 2020;26(50):11584-11592doi: 10.1002/chem.202002026.
Kraszewski, K., Tomczyk, I., Drabinska, A., Bienkowski, K., Solarska, R., & Kalek, M. (2020). Mechanism of Iodine(III)-Promoted Oxidative Dearomatizing Hydroxylation of Phenols: Evidence for a Radical-Chain Pathway. Chemistry (Weinheim an der Bergstrasse, Germany), 26(50), 11584-11592. https://doi.org/10.1002/chem.202002026
Kraszewski, Karol, et al. "Mechanism of Iodine(III)-Promoted Oxidative Dearomatizing Hydroxylation of Phenols: Evidence for a Radical-Chain Pathway." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 26,50 (2020): 11584-11592. doi: https://doi.org/10.1002/chem.202002026
Kraszewski K, Tomczyk I, Drabinska A, Bienkowski K, Solarska R, Kalek M. Mechanism of Iodine(III)-Promoted Oxidative Dearomatizing Hydroxylation of Phenols: Evidence for a Radical-Chain Pathway. Chemistry. 2020 Sep 04;26(50):11584-11592. doi: 10.1002/chem.202002026. Epub 2020 Aug 10. PMID: 32608529.
Copy Download .nbib Format: NLM
The Luminescence of 1,8-Diazafluoren-9-One/Titanium Dioxide Composite Thin Films for Optical Application.

Materials (Basel, Switzerland)

Lewkowicz A, Bogdanowicz R, Bojarski P, Pierpaoli M, Gryczyński I, Synak A, Mońka M, Karczewski J, Struck-Lewicka W, Wawrzyniak R, Markuszewski MJ.
PMID: 32640655
Materials (Basel). 2020 Jul 06;13(13). doi: 10.3390/ma13133014.

The investigation of innovative label-free α-amino acids detection methods represents a crucial step for the early diagnosis of several diseases. While 1,8-diazafluoren-9-one (DFO) is known in forensic application because of the fluorescent products by reacting with the amino acids...

Cite
Lewkowicz A, Bogdanowicz R, Bojarski P, et al. The Luminescence of 1,8-Diazafluoren-9-One/Titanium Dioxide Composite Thin Films for Optical Application. Materials (Basel). 2020;13(13)doi: 10.3390/ma13133014.
Lewkowicz, A., Bogdanowicz, R., Bojarski, P., Pierpaoli, M., Gryczyński, I., Synak, A., Mońka, M., Karczewski, J., Struck-Lewicka, W., Wawrzyniak, R., & Markuszewski, M. J. (2020). The Luminescence of 1,8-Diazafluoren-9-One/Titanium Dioxide Composite Thin Films for Optical Application. Materials (Basel, Switzerland), 13(13), . https://doi.org/10.3390/ma13133014
Lewkowicz, Aneta, et al. "The Luminescence of 1,8-Diazafluoren-9-One/Titanium Dioxide Composite Thin Films for Optical Application." Materials (Basel, Switzerland) vol. 13,13 (2020). doi: https://doi.org/10.3390/ma13133014
Lewkowicz A, Bogdanowicz R, Bojarski P, Pierpaoli M, Gryczyński I, Synak A, Mońka M, Karczewski J, Struck-Lewicka W, Wawrzyniak R, Markuszewski MJ. The Luminescence of 1,8-Diazafluoren-9-One/Titanium Dioxide Composite Thin Films for Optical Application. Materials (Basel). 2020 Jul 06;13(13). doi: 10.3390/ma13133014. PMID: 32640655; PMCID: PMC7372385.
Copy Download .nbib Format: NLM
Blowing Kinetics, Pressure Resistance, Thermal Stability, and Relaxation of the Amorphous Phase of the PET Container in the SBM Process with Hot and Cold Mold. Part II: Statistical Analysis and Interpretation of Tests.

Polymers

Wawrzyniak P, Karaszewski W.
PMID: 32781692
Polymers (Basel). 2020 Aug 06;12(8). doi: 10.3390/polym12081761.

The technology of filling drinks without preservatives (such as fresh juices, iced tea drinks, and vitaminized drinks) is carried out using hot filling. Mainly due to the production costs and lower carbon footprint, polyethylene terephthalate (PET) bottles are increasingly...

Cite
Wawrzyniak P, Karaszewski W. Blowing Kinetics, Pressure Resistance, Thermal Stability, and Relaxation of the Amorphous Phase of the PET Container in the SBM Process with Hot and Cold Mold. Part II: Statistical Analysis and Interpretation of Tests. Polymers (Basel). 2020;12(8)doi: 10.3390/polym12081761.
Wawrzyniak, P., & Karaszewski, W. (2020). Blowing Kinetics, Pressure Resistance, Thermal Stability, and Relaxation of the Amorphous Phase of the PET Container in the SBM Process with Hot and Cold Mold. Part II: Statistical Analysis and Interpretation of Tests. Polymers, 12(8), . https://doi.org/10.3390/polym12081761
Wawrzyniak, Paweł, and Karaszewski, Waldemar. "Blowing Kinetics, Pressure Resistance, Thermal Stability, and Relaxation of the Amorphous Phase of the PET Container in the SBM Process with Hot and Cold Mold. Part II: Statistical Analysis and Interpretation of Tests." Polymers vol. 12,8 (2020). doi: https://doi.org/10.3390/polym12081761
Wawrzyniak P, Karaszewski W. Blowing Kinetics, Pressure Resistance, Thermal Stability, and Relaxation of the Amorphous Phase of the PET Container in the SBM Process with Hot and Cold Mold. Part II: Statistical Analysis and Interpretation of Tests. Polymers (Basel). 2020 Aug 06;12(8). doi: 10.3390/polym12081761. PMID: 32781692; PMCID: PMC7463488.
Copy Download .nbib Format: NLM
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib.

Clinical cancer research : an official journal of the American Association for Cancer Research

Brase JC, Walter RFH, Savchenko A, Gusenleitner D, Garrett J, Schimming T, Varaljai R, Castelletti D, Kim J, Dakappagari N, Schultz K, Robert C, Long GV, Nathan PD, Ribas A, Flaherty KT, Karaszewska B, Schachter J, Sucker A, Schmid KW, Zimmer L, Livingstone E, Gasal E, Schadendorf D, Roesch A.
PMID: 34108180
Clin Cancer Res. 2021 Aug 15;27(16):4500-4510. doi: 10.1158/1078-0432.CCR-20-3586. Epub 2021 Jun 09.

PURPOSE: Although patients with unresectable or metastatic melanoma can experience long-term survival with BRAF- and MEK-targeted agents or immune checkpoint inhibitors over 5 years, resistance develops in most patients. There is a distinct lack of pretherapeutic biomarkers to identify...

Cite
Brase JC, Walter RFH, Savchenko A, et al. Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib. Clin Cancer Res. 2021;27(16):4500-4510doi: 10.1158/1078-0432.CCR-20-3586.
Brase, J. C., Walter, R. F. H., Savchenko, A., Gusenleitner, D., Garrett, J., Schimming, T., Varaljai, R., Castelletti, D., Kim, J., Dakappagari, N., Schultz, K., Robert, C., Long, G. V., Nathan, P. D., Ribas, A., Flaherty, K. T., Karaszewska, B., Schachter, J., Sucker, A., Schmid, K. W., Zimmer, L., Livingstone, E., Gasal, E., Schadendorf, D., & Roesch, A. (2021). Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(16), 4500-4510. https://doi.org/10.1158/1078-0432.CCR-20-3586
Brase, Jan C, et al. "Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,16 (2021): 4500-4510. doi: https://doi.org/10.1158/1078-0432.CCR-20-3586
Brase JC, Walter RFH, Savchenko A, Gusenleitner D, Garrett J, Schimming T, Varaljai R, Castelletti D, Kim J, Dakappagari N, Schultz K, Robert C, Long GV, Nathan PD, Ribas A, Flaherty KT, Karaszewska B, Schachter J, Sucker A, Schmid KW, Zimmer L, Livingstone E, Gasal E, Schadendorf D, Roesch A. Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib. Clin Cancer Res. 2021 Aug 15;27(16):4500-4510. doi: 10.1158/1078-0432.CCR-20-3586. Epub 2021 Jun 09. PMID: 34108180.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 102 entries